NANEXA.ST
Price:
$3.395
Market Cap:
$538.71M
Nanexa AB (publ) operates as a nanotechnology drug delivery company. It operates PharmaShell, a nanobased drug delivery platform that is an atomic layer deposition. The company also develops NEX-18, which drives the development of a PharmaShell that targets myelodysplastic Syndrome and Acute Myeloid Leukemia. Nanexa AB (publ) was founded in 2007 and is based in Uppsala, Sweden.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2015-06-17
Stock Exchange
STO
Ticker
NANEXA.ST
According to Nanexa AB (publ)’s latest financial reports and current stock price. The company's current ROE is -47.00%. This represents a change of 285.94% compared to the average of -12.18% of the last 4 quarters.
The mean historical ROE of Nanexa AB (publ) over the last ten years is -49.76%. The current -47.00% ROE has changed -5.54% with respect to the historical average. Over the past ten years (40 quarters), NANEXA.ST's ROE was at its highest in in the March 2024 quarter at -3.04%. The ROE was at its lowest in in the December 2023 quarter at -53.38%.
Average
-49.76%
Median
-51.10%
Minimum
-79.72%
Maximum
-23.79%
Discovering the peaks and valleys of Nanexa AB (publ) ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 136.20%
Maximum Annual ROE = -23.79%
Minimum Annual Increase = -55.95%
Minimum Annual ROE = -79.72%
| Year | ROE | Change |
|---|---|---|
| 2024 | -35.11% | -55.95% |
| 2023 | -79.72% | 48.49% |
| 2022 | -53.69% | 125.63% |
| 2021 | -23.79% | -52.54% |
| 2020 | -50.14% | -3.68% |
| 2019 | -52.05% | -24.09% |
| 2018 | -68.57% | 136.20% |
| 2017 | -29.03% | -22.43% |
| 2016 | -37.43% | -44.98% |
| 2015 | -68.03% | 7.69% |
The current ROE of Nanexa AB (publ) (NANEXA.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-56.17%
5-year avg
-48.49%
10-year avg
-49.76%
Nanexa AB (publ)’s ROE is greater than AlzeCure Pharma AB (publ) (-157.97%), less than Xintela AB (publ) (245.05%), greater than Acarix AB (publ) (-94.56%), greater than Elicera Therapeutics AB (publ) (-45.82%), greater than Enorama Pharma AB (publ) (-1477.99%), greater than Moberg Pharma AB (publ) (-37.79%), greater than Promimic AB (publ) (-18.79%), greater than Boule Diagnostics AB (publ) (-3.83%), greater than Mentice AB (publ) (-36.09%), greater than Physitrack PLC (-34.85%),
| Company | ROE | Market cap |
|---|---|---|
| -157.97% | $243.62M | |
| 245.05% | $181.47M | |
| -94.56% | $310.63M | |
| -45.82% | $263.55M | |
| -1477.99% | $170.06M | |
| -37.79% | $437.11M | |
| -18.79% | $268.27M | |
| -3.83% | $208.92M | |
| -36.09% | $346.65M | |
| -34.85% | $211.39M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nanexa AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nanexa AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Nanexa AB (publ)'s ROE?
How is the ROE calculated for Nanexa AB (publ) (NANEXA.ST)?
What is the highest ROE for Nanexa AB (publ) (NANEXA.ST)?
What is the 3-year average ROE for Nanexa AB (publ) (NANEXA.ST)?
What is the 5-year average ROE for Nanexa AB (publ) (NANEXA.ST)?
How does the current ROE for Nanexa AB (publ) (NANEXA.ST) compare to its historical average?